Zacks Investment Research
11 Feb 2026, 15:40 UTC · 37w ago
Verdict
Headline takes no side. We score ALLO +0.80 across four claims — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Allogene Therapeutics holds a Zacks Rank of #2 (Buy) and its full-year earnings consensus estimate has increased 0.3% over the past three months.
More positive than 62% of claims this week
Allogene Therapeutics has returned 23.4% year-to-date, significantly outperforming the Medical sector's average return of 0.9% and its specific industry's average gain of 6.5%.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 49% of claims this week
McKesson holds a Zacks Rank of #2 (Buy) and its consensus EPS estimate for the current year has increased 0.9% over the past three months.
More positive than 42% of claims this week
McKesson has returned 14% year-to-date, outperforming its Medical - Dental Supplies industry average gain of 4.5%.
More positive than 40% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company has a Zacks Rank of #2 (Buy), positive earnings estimate revisions, and is significantly outperforming its sector.
More positive than 75% of ticker scores this week
The company has a Zacks Rank of #2 (Buy), increasing EPS estimates, and has outperformed the sector year-to-date.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
17h ago
−30.2%
Price is moving against the score
$1.18 vs $1.69 close before publication (Feb 10) · not market-adjusted
ALLO chart →
